Buy One Get One free -Llimited Time Offer X
Granfill is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Neutropenia.
The optimal dosage of Granfill is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Granfill side effects, there are can be others also. These have been listed below. Such side effects of Granfill normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Granfill has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Granfill's effects on the liver, heart and kidney are discussed below in the Granfill related warnings section.
Granfill can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Granfill in conditions like Blood Cancer. The section on Granfill contraindications lists all such conditions.
Additionally, Granfill may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Granfill, it is important to know that it is safe while driving, and is habit-forming.
Granfill is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Granfill is used -
Moderate
Mild
Is the use of Granfill safe for pregnant women?
Granfill may have some side effects during pregnancy. Pregnant women should discontinue the use of Granfill, and talk to their doctor, if they notice any discomfort.
Is the use of Granfill safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Granfill. Immediately discontinue Granfill if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Granfill on the Kidneys?
Granfill may have mild side effects on the kidneys.
What is the effect of Granfill on the Liver?
Granfill is rarely harmful for the liver.
What is the effect of Granfill on the Heart?
The heart can be affected by Granfill. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Granfill should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Granfill unless your doctor advises you to do so -
Is this Granfill habit forming or addictive?
No, there is no any evidence that Granfill is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Granfill since it does not cause drowsiness.
Is it safe?
Granfill is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Granfill in mental disorders is not effective.
Interaction between Food and Granfill
There isn't any research available on the side effects of taking Granfill with food.
Interaction between Alcohol and Granfill
No research has been done on this till date. Therefore, it is not known what the effect of taking Granfill with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560